• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Venus Remedies Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526953
INE411B01019
515.9180123
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VENUSREM
24.25
2407.73
EPS(TTM)
Face Value()
Div & Yield %
74.29
10
0.56
 

Hikal consolidated net profit declines 71.31% in the March 2026 quarter
May 27,2026
Net profit of Hikal declined 71.31% to Rs 14.40 crore in the quarter ended March 2026 as against Rs 50.20 crore during the previous quarter ended March 2025. Sales declined 6.00% to Rs 517.00 crore in the quarter ended March 2026 as against Rs 550.00 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 48.80 crore in the year ended March 2026 as against net profit of Rs 90.80 crore during the previous year ended March 2025. Sales declined 8.04% to Rs 1695.20 crore in the year ended March 2026 as against Rs 1843.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales517.00550.00 -6 1695.201843.50 -8
OPM %20.3922.44 -13.0017.81 -
PBDT97.40106.00 -8 170.60258.20 -34
PBT55.4068.30 -19 6.80123.80 -95
NP14.4050.20 -71 -48.8090.80 PL